Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Morphine to relieve exertional dyspnoea in COPD: myth, dream or reality?

Laviolette L, Laveneziana P.

Eur Respir J. 2017 Oct 19;50(4). pii: 1701865. doi: 10.1183/13993003.01865-2017. Print 2017 Oct. No abstract available.

2.

Exertional dyspnoea and cortical oxygenation in patients with COPD.

Higashimoto Y, Honda N, Yamagata T, Sano A, Nishiyama O, Sano H, Iwanaga T, Kume H, Chiba Y, Fukuda K, Tohda Y.

Eur Respir J. 2015 Dec;46(6):1615-24. doi: 10.1183/13993003.00541-2015. Epub 2015 Oct 22.

3.

Six-minute walk distance and dyspnoea scores to assess the course of COPD exacerbation in elderly patients.

Blankenburg T, Guettel A, Busch C, Schuette W.

Clin Respir J. 2013 Jul;7(3):261-7. doi: 10.1111/j.1752-699X.2012.00314.x. Epub 2012 Aug 24.

PMID:
22823008
4.

Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest.

Boni E, Corda L, Franchini D, Chiroli P, Damiani GP, Pini L, Grassi V, Tantucci C.

Thorax. 2002 Jun;57(6):528-32.

5.

Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea.

Diba C, King GG, Berend N, Salome CM.

Respir Med. 2011 Sep;105(9):1345-51. doi: 10.1016/j.rmed.2011.03.013. Epub 2011 Apr 8.

6.

Effect of morphine on breathlessness and exercise endurance in advanced COPD: a randomised crossover trial.

Abdallah SJ, Wilkinson-Maitland C, Saad N, Li PZ, Smith BM, Bourbeau J, Jensen D.

Eur Respir J. 2017 Oct 19;50(4). pii: 1701235. doi: 10.1183/13993003.01235-2017. Print 2017 Oct.

7.

[Effect of dynamic hyperinflation on exertional dyspnea, exercise performance and quality of life in COPD].

Ozgur ES, Atis S, Kanik A.

Tuberk Toraks. 2008;56(3):296-303. Turkish.

PMID:
18932031
8.

Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: comparison with COPD.

Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Kato K, Ogawa T, Watanabe F, Arizono S.

Respir Med. 2007 Apr;101(4):833-8. Epub 2006 Sep 8.

9.

[Neuromuscular electrical stimulation improves the functional level in patients with severe chronic obstructive pulmonary disease].

Al-Gibouri S, Ringbæk T, Lange P.

Ugeskr Laeger. 2013 Apr 22;175(17):1185-8. Review. Danish.

PMID:
23651783
10.

Inspiratory capacity and forced expiratory volume in the first second in exacerbation of chronic obstructive pulmonary disease.

Yetkin O, Gunen H.

Clin Respir J. 2008 Jan;2(1):36-40. doi: 10.1111/j.1752-699X.2007.00040.x.

PMID:
20298302
11.

Association of chronic nasal symptoms with dyspnoea and quality-of-life impairment in chronic obstructive pulmonary disease.

Caillaud D, Chanez P, Escamilla R, Burgel PR, Court-Fortune I, Nesme-Meyer P, Deslee G, Perez T, Pinet C, Roche N; Initiatives BPCO Scientific Committee and Investigators.

Respirology. 2014 Apr;19(3):346-52. doi: 10.1111/resp.12224. Epub 2013 Dec 15.

12.

Does exercise test modality influence dyspnoea perception in obese patients with COPD?

Ciavaglia CE, Guenette JA, Ora J, Webb KA, Neder JA, O'Donnell DE.

Eur Respir J. 2014 Jun;43(6):1621-30. doi: 10.1183/09031936.00151513. Epub 2013 Dec 5.

13.

Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.

Jensen D, Amjadi K, Harris-McAllister V, Webb KA, O'Donnell DE.

Thorax. 2008 Jul;63(7):606-13. doi: 10.1136/thx.2007.085993. Epub 2008 Feb 4.

PMID:
18250181
14.

Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD.

Mahler DA, Murray JA, Waterman LA, Ward J, Kraemer WJ, Zhang X, Baird JC.

Eur Respir J. 2009 Apr;33(4):771-7. doi: 10.1183/09031936.00145208. Epub 2009 Feb 12.

15.

Should we use gait speed in COPD, FEV1 in frailty and dyspnoea in both?

Bousquet J, Dinh-Xuan AT, Similowski T, Malva J, Ankri J, Barbagallo M, Fabbri L, Humbert M, Mercier J, Robalo-Cordeiro C, Rodriguez-Manas L, Vellas B.

Eur Respir J. 2016 Aug;48(2):315-9. doi: 10.1183/13993003.00633-2016. No abstract available.

16.

[Relationship between degree of dyspnoea and health-related quality of life in patients with chronic obstructive pulmonary disease].

Gvozdenović BS, Mitić S, Zugić VG, Gvozdenović AT, Lazović NM, Plavsić S.

Srp Arh Celok Lek. 2007 Sep-Oct;135(9-10):547-53. Serbian.

17.

Three-minute constant rate step test for detecting exertional dyspnea relief after bronchodilation in COPD.

Borel B, Wilkinson-Maitland CA, Hamilton A, Bourbeau J, Perrault H, Jensen D, Maltais F.

Int J Chron Obstruct Pulmon Dis. 2016 Nov 29;11:2991-3000. eCollection 2016.

18.

Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease.

Ofir D, Laveneziana P, Webb KA, Lam YM, O'Donnell DE.

Am J Respir Crit Care Med. 2008 Mar 15;177(6):622-9. Epub 2007 Nov 15.

PMID:
18006885
19.

[Oxygen therapy in exercise-induced hypoxemia improves physical capacity and reduces dyspnea in patients with COPD].

Kjeldgaard P, Ringbæk T, Lange P.

Ugeskr Laeger. 2011 Jun 6;173(23):1635-40. Review. Danish.

PMID:
21645481
20.

A randomised trial of domiciliary, ambulatory oxygen in patients with COPD and dyspnoea but without resting hypoxaemia.

Moore RP, Berlowitz DJ, Denehy L, Pretto JJ, Brazzale DJ, Sharpe K, Jackson B, McDonald CF.

Thorax. 2011 Jan;66(1):32-7. doi: 10.1136/thx.2009.132522. Epub 2010 Sep 29.

PMID:
20880870

Supplemental Content

Support Center